Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0018 (13.64%)
At close: Mar 4, 2026
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $642.75 thousand as of March 5, 2026. Its market cap has decreased by -87.51% in one year.
Market Cap
642.75K
Enterprise Value
3.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 642.75K, a decrease of -99.98%. That is a compound annual growth rate of -26.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 565.62K | -51.13% |
| Dec 31, 2025 | 1.16M | -70.01% |
| Dec 31, 2024 | 3.86M | 4.27% |
| Dec 29, 2023 | 3.70M | -43.61% |
| Dec 30, 2022 | 6.56M | -85.53% |
| Dec 31, 2021 | 45.36M | -47.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scorpius Holdings | 739.83K |
| Lipella Pharmaceuticals | 716.69K |
| SQZ Biotechnologies Company | 710.74K |
| Bio-Path Holdings | 642.74K |
| Helix BioMedix | 606.71K |
| Altamira Therapeutics | 571.55K |
| Aibotics | 538.09K |
| Hepion Pharmaceuticals | 424.72K |